Tobira Therapeutics, a clinical-stage biopharmaceutical company advancing cenicriviroc in liver disease and HIV, announced today that Laurent Fischer, MD, Tobira's Chairman of the Board, has been appointed Chief Executive Officer.
http://ift.tt/P2C2CJ
http://ift.tt/P2C2CJ
No comments:
Post a Comment